Tolvaptan and Hyponatremia in a Patient with Cirrhosis

被引：22

作者：

Boyer, Thomas D. ^{[1
]}

机构：

[1] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA

来源：

HEPATOLOGY | 2010年 / 51卷 / 02期

关键词：

SERUM SODIUM; LIVER-TRANSPLANTATION; RECEPTOR ANTAGONIST; ASCITES; SATAVAPTAN; MANAGEMENT; TRIAL;

D O I：

10.1002/hep.23522

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：699 / 702

页数：4

相关论文

共 12 条

[1]

Hyponatremia in cirrhosis:: Results of a patient population survey [J].

Angeli, Paolo ;

Wong, Florence ;

Watson, Hugh ;

Gines, Pere .

HEPATOLOGY, 2006, 44 (06) :1535-1542

[2]

Serum sodium predicts mortality in patients listed for liver transplantation [J].

Biggins, SW ;

Rodriguez, HJ ;

Bacchetti, P ;

Bass, NM ;

Roberts, JP ;

Terrault, NA .

HEPATOLOGY, 2005, 41 (01) :32-39

[3]

Hyponatremia in cirrhosis:: From pathogenesis to treatment [J].

Ginés, P ;

Berl, T ;

Bernardi, M ;

Bichet, DG ;

Hamon, G ;

Jiménez, W ;

Liard, JF ;

Martin, PY ;

Schrier, RW .

HEPATOLOGY, 1998, 28 (03) :851-864

[4]

Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia:: A randomized trial [J].

Gines, Pere ;

Wong, Florence ;

Watson, Hugh ;

Milutinovic, Slobodan ;

del Arbol, Luis Ruiz ;

Olteanu, Dan .

HEPATOLOGY, 2008, 48 (01) :204-213

[5]

The management of ascites and hyponatremia in cirrhosis [J].

Gines, Pere ;

Cardenas, Andres .

SEMINARS IN LIVER DISEASE, 2008, 28 (01) :43-58

[6]

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death [J].

Heuman, DM ;

Abou-assi, SG ;

Habib, A ;

Williams, LM ;

Stravitz, RT ;

Sanyal, AJ ;

Fisher, RA ;

Mihas, AA .

HEPATOLOGY, 2004, 40 (04) :802-810

[7]

Vasopressin antagonists in the treatment of water-retaining disorders [J].

Kumar, Sumit ;

Berl, Tomas .

SEMINARS IN NEPHROLOGY, 2008, 28 (03) :279-288

[8]

Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation [J].

Londoño, MC ;

Guevara, M ;

Rimola, A ;

Navasa, M ;

Taurà, P ;

Mas, A ;

García-Valdecasas, JC ;

Arroyo, V ;

Ginès, P .

GASTROENTEROLOGY, 2006, 130 (04) :1135-1143

[9]

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia [J].

Schrier, Robert W. ;

Gross, Peter ;

Gheorghiade, Mihai ;

Berl, Tomas ;

Verbalis, Joseph G. ;

Czerwiec, Frank S. ;

Orlandi, Cesare .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (20) :2099-2112

[10]

PERIPHERAL ARTERIAL VASODILATION HYPOTHESIS - A PROPOSAL FOR THE INITIATION OF RENAL SODIUM AND WATER-RETENTION IN CIRRHOSIS [J].

SCHRIER, RW ;

ARROYO, V ;

BERNARDI, M ;

EPSTEIN, M ;

HENRIKSEN, JH ;

RODES, J .

HEPATOLOGY, 1988, 8 (05) :1151-1157